Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial

BACKGROUND: While several phase III trials have investigated the role of hypofractionated radiotherapy in the definitive treatment of localized prostate cancer, prospective data reporting the outcomes of hypofractionated radiotherapy in the postoperative treatment setting are sparse. Therefore, this...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Geumju, Kim, Yeon Joo, Ahn, Hanjong, Park, Won, Lee, Ji sung, Kim, Young Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532339/
https://www.ncbi.nlm.nih.gov/pubmed/34674739
http://dx.doi.org/10.1186/s13063-021-05708-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532339/
https://www.ncbi.nlm.nih.gov/pubmed/34674739
http://dx.doi.org/10.1186/s13063-021-05708-5

Ejemplares similares